Skip to main content
SpringerLink
Log in
Book cover

Nutrition in Kidney Disease pp 191–226Cite as

Nutrition and Pharmacologic Approaches

  • Chapter

  • 1581 Accesses

Part of the book series: Nutrition and Health ((NH))

Summary

Chronic kidney disease (CKD) is a worldwide public health problem and a progressive, debilitating condition. People with CKD are at high risk of malnutrition, and the first priority of nutrition therapy must focus on the prevention and/or treatment of protein energy malnutrition. Additional nutrition therapy goals include slowing the progression of CKD and its uremic complications and preventing renal osteodystrophy, cardiovascular disease, and diabetic complications. Nutrition and pharmaceutical therapies which address these issues are complex, but with appropriate intervention patients can maintain nutrition health, slow the progression to stage 5 CKD, stabilize cardiac status, and reduce diabetic complications. Successful nutrition therapy includes the active involvement of a qualified renal dietitian.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   179.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   229.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. NKF KDOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39:S37–S75, S112–S155, S170–S212.

    Article  Google Scholar 

  2. National Kidney Foundation at http://www.kidney.org/kidneyDisease/. Accessed January 28, 2006.

    Google Scholar 

  3. U.S. Renal Data System. USRDS 2006 Annual Data Report: atlas of chronic kidney disease and end-stage renal disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2006.

    Google Scholar 

  4. Shulman, NB, Ford CE, Hall WD, Blaufox MD, Simon D, Langford HG, Schneider KA. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the Hypertension Detection and Follow-up Program (HDFP). The Hypertension Detection and Follow-Up Program Cooperative Group. Hypertension 1989;13:S180–S193.

    Google Scholar 

  5. Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 2004;164:659–663.

    Article  PubMed  Google Scholar 

  6. Go AS, Chertow GM, Fan D, McCulloch CD, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351:1296–1305.

    Article  PubMed  CAS  Google Scholar 

  7. Kopple JD, Greene T, Chumlea WC, Hollinger D, Maroni BJ, Merrill D, Scherch LK, Schulman G, Wang S, Zimmer GS. Relationship between nutritional status and the glomerular filtration rate: Results from the MDRD Study. Kidney Int 2000;57:1688–1703.

    Article  PubMed  CAS  Google Scholar 

  8. Ikizler TA, Green JH, Wingard RL, Parker RA, Hakim RM. Spontaneous dietary protein intake during progression of chronic renal failure. J Am Soc of Nephrol 1995;6:1386–1391.

    CAS  Google Scholar 

  9. Mitch WE, Maroni BJ. Factors causing malnutrition in patients with chronic uremia. Am J Kidney Dis 1999;33:176–179.

    Article  PubMed  CAS  Google Scholar 

  10. Stenvinkel P, Heimburger O, Paultre F, Diczfalusy U, Wang T, Berglund L, Jogestrand T. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999;55:1899–1911.

    Article  PubMed  CAS  Google Scholar 

  11. Rose BD. Protein restriction and progression of chronic kidney disease. www.uptodate.com 2005;13.2:1–12.

    Google Scholar 

  12. Ihle BU, Becher GJ, Whitworth JA, Charlwood RA, Kincaid-Smith PS. The effect of protein restriction on the progression of renal insufficiency. N Engl J Med 1989;321:1773–1777.

    PubMed  CAS  Google Scholar 

  13. Walser M, Hill SB, Ward L, Magder L. A crossover comparison of progression of chronic renal failure: Ketoacids versus amino acids. Kidney Int 1993;43:933–939.

    Article  PubMed  CAS  Google Scholar 

  14. Walser M, Hill S. Can renal replacement be deferred by a supplemented very low protein diet? J Am Soc Nephrol 1999;10:110–116.

    PubMed  CAS  Google Scholar 

  15. Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, Striker G. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. N Engl J Med 1994;330:877–884.

    Article  PubMed  CAS  Google Scholar 

  16. Levey AS, Green T, Beck GJ, Caggiula AW, Kusek JW, Hunsicker LG, Klahr S. Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? J Am Soc Nephrol 1999;10: 2426–2439.

    PubMed  CAS  Google Scholar 

  17. Fouque D, Laville M, Boissel JP, Chifflet R, Labeeuw M, Zech PY. Controlled low protein diets in chronic renal insufficiency: meta-analysis. BMJ 1992;304:216–220.

    Article  PubMed  CAS  Google Scholar 

  18. Fouque D, Wang P, Laville M, Boissel JP. Low protein diets for chronic renal failure in non diabetic adults (Cochran Review). In: The Cochran Library, 2000. Oxford: Update Software, p. 4.

    Google Scholar 

  19. Elliot P, Stamler J, Dyer AR, Appel L, Dennis B, Kesteloot H, Ueshima H, Okayama A, Chan Q, Garside DB, Zhoe B. Association between protein intake and blood pressure. Arch Intern Med 2006;166:79–87.

    Article  Google Scholar 

  20. Soroka N, Silverberg DS, Greemland M, Birk Y, Blum M, Peer G, Iaina A. Comparison of a vegetable-based (soya) and an animal-based low-protein diet in predialysis chronic renal failure patients. Nephron 1998;79:173–180.

    Article  PubMed  CAS  Google Scholar 

  21. Anderson JW, Blake JE, Turner J, Smith BM. Effects of soy protein on renal function and proteinuria in patients with type 2 diabetes. Am J Clin Nutr 1998;68:1348S–1353S.

    Google Scholar 

  22. Wheeler ML, Fineberg SE, Fineberg NS, Gibson RG, Hackward LL. Animal versus plant protein meals in individuals with type 2 diabetes and microalbuminuria, effects on renal, glycemic and lipid parameters. Diabetes Care 2002;25:1277–1282.

    Article  PubMed  Google Scholar 

  23. Stephenson TJ, Setchell KD, Kendall CW, Jenkins DJ, Anderson JW, Fanti P. Effect of soy protein-rich diet on renal function in young adults with insulin-dependent diabetes mellitus. Clin Nephrol 2005;64:1–11.

    PubMed  CAS  Google Scholar 

  24. Teixeira SR, Tappenden KA, Carson LA, Jones R, Prabhudesai M, Marchall WP, Erdman JW. Isolated soy protein consumption reduces urinary albumin excretion and improves the serum lipid profile in men with type 2 diabetes mellitus and nephropathy. J Nutr 2004;134:1874–1880.

    PubMed  CAS  Google Scholar 

  25. Castaneda C, Gordon PL, Uhlin KL, Levey AS, Kehayias JL, Dwyer JT, Fielding RA, Roubenoff R, Singh MF. Resistance training to counteract the catabolism of a low-protein diet in patients with chronic renal insufficiency. Ann Intern Med 2001;135:965–976.

    PubMed  CAS  Google Scholar 

  26. NKF KDOQI clinical practice guidelines for nutrition in chronic renal failure. Am J Kidney Dis 2000;35:S58–S61.

    Article  Google Scholar 

  27. NKF KDOQI clinical practice guidelines for hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 2004;43:S16–230 (Guideline 1,5,6,7,9).

    Article  Google Scholar 

  28. Wiggins KL. Guideline 2, Nutrition Care of Adult Dialysis Patients. In: Guidelines for Nutrition Care of Renal Patients, 3rd ed. Chicago: American Dietetic Association, 2002, pp. 5–18.

    Google Scholar 

  29. Maroni BJ, Staffield C, Young VR, Manatunga A, Tom K. Mechanisms permitting nephrotic patients to achieve nitrogen equilibrium with a protein-restricted diet. J Clin Invest 1997;99:2479–2487.

    Article  PubMed  CAS  Google Scholar 

  30. Walser M, Hill S, Tomalis EA. Treatment of nephrotic adults with a supplemented, very low-protein diet. Am J Kidney Dis 1996;28:354–364.

    Article  PubMed  CAS  Google Scholar 

  31. D’Amico G, Gentile MG, Manna G, Fellin G, Ciceri R, Cofano CR, Petrini C, Lavarda F, Perolini S, Porrini M. Effect of vegetarian soy diet on hyperlipidaemia in nephrotic syndrome. Lancet 1992;339:1131–1134.

    Article  PubMed  CAS  Google Scholar 

  32. Gentile MG, Fellin G, Cofano F, Delle Fave A, Manna G, Ciceri R, Petrini C, Lavarda F, Possi F, D’Amico G. Treatment of proteinuric patients with a vegetarian soy diet and fish oil. Clin Nephrol 1993;40:315–320.

    PubMed  CAS  Google Scholar 

  33. Monteon FJ, Laidlaw SA, Shaib JK, Kopple JD. Energy expenditure in patients with chronic renal failure. Kidney Int 1986;30:741–747.

    Article  PubMed  CAS  Google Scholar 

  34. Kopple JD, Monteon FJ, Shaib JK. Effect of energy intake on nitrogen metabolism in nondialyzed patients with chronic renal failure. Kidney Int 1986;29:734–742.

    Article  PubMed  CAS  Google Scholar 

  35. Kuhlmann U, Schwidkardi M, Trebst R, Lange H. Resting metabolic rate in chronic renal failure. J Ren Nutr 2001;11:202–206.

    Article  PubMed  CAS  Google Scholar 

  36. Passey C, Bunker V, Jackson A, Lee H. Energy balance in predialysis patients on a low-protein diet. J Ren Nutr 2003;13:120–125.

    Article  PubMed  Google Scholar 

  37. Chauveau P, Barthe N, Rigalleau V, Ozenne S, Castaing F, Delclaux C, de Precigout V, Combe C, Aparicio M. Outcome of Nutritional Status and Body Composition of Uremic Patients on a Very Low Protein Diet. Am J Kidney Dis 1999;34:500–507.

    Article  PubMed  CAS  Google Scholar 

  38. Guarnieri GF, Toigo G, Situlin R, Carraro M, Tamaro G, Lucchesli A, Oldrizzi L, Rugiu C Maschio G. Nutritional state in patients on long-term low-protein diet or with nephrotic syndrome. Kidney Int 1989;36:S195–S199.

    Google Scholar 

  39. Byham-Gray LD. Weighing the evidence: energy determinations across the spectrum of kidney disease. J Ren Nutr 2006;16:17–26.

    Article  PubMed  Google Scholar 

  40. Wiggins KL. Vitamins and minerals in chronic kidney disease. In: Renal Care: Resources and Practical Applications. Chicago: American Dietetic Association, 2004, pp. 39–60.

    Google Scholar 

  41. Martinez I, Saracho R, Montenegro J, Llach F. The importance of dietary calcium and phosphorous in the secondary hyperparathyroidism of patients with early renal failure. Am J Kidney Dis 1997;29:496–502.

    Article  PubMed  CAS  Google Scholar 

  42. NKF KDOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003;42: S29–S91.

    Google Scholar 

  43. Reichel H, Deibert B, Schmidt-Gayk H, Ritz E. Calcium metabolism in early chronic renal failure: implications for the pathogenesis of hyperparathyroidism. Nephrol Dial Transplant 1991;6:162–169.

    PubMed  CAS  Google Scholar 

  44. Barsotti G, Morelli E, Guiducci A, Ciardella F, Giannoni A, Lupetti S, Giovannetti S. Reversal of hyperparathyroidism in severe uremics following very low-protein and low-phosphorus diet. Nephron 1982;30:310–313.

    PubMed  CAS  Google Scholar 

  45. Barsotti G, Cupisti A. The role of dietary phosphorus restriction in the conservative management of chronic renal disease. J Ren Nutr 2005;15:189–192.

    Article  PubMed  Google Scholar 

  46. Cochran M, Coates PT, Morris HA. The effect of calcitriol on fasting urine calcium loss and renal tubular reabsorption of calcium in patients with mild renal failure–actions of a permissive hormone. Clin Nephrol 2005;64:98–102.

    PubMed  CAS  Google Scholar 

  47. Andress DL. Vitamin D in chronic kidney disease: A systemic role for selective vitamin D receptor activation. Kidney Int 2006;69:33–43.

    Article  PubMed  CAS  Google Scholar 

  48. Yumita S, Suzuki M, Akiba T, Akizawa T, Seino Y, Kurokawa K. Levels of serum 1,25(OH)2D in patients with pre-dialysis chronic renal failure. Tohoku J Exp Med 1996;180:45–56.

    Article  PubMed  CAS  Google Scholar 

  49. Kramer H, Toto R, Peshock R, Cooper R, Victor R. Association between chronic kidney disease and coronary artery calcification: the Dallas Heart Study. J Am Soc Nephrol 2005;16:507–513.

    Article  PubMed  Google Scholar 

  50. NKF KDOQI clinical practice guidelines for anemia of chronic kidney disease update 2000. Am J Kidney Dis 2001;37:S182–238. (Guideline 1–12,15,16,20).

    Article  Google Scholar 

  51. Culleton BF, Larson MG, Wilson PWF, Evans JC, Parfrey PS, Levy D. Cardiovasculare disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int 1999;56:2214–2219.

    Article  PubMed  CAS  Google Scholar 

  52. Keough-Ryan TM, Kiberd BA, Dipchand CS, Cox JL, Rose CL, Thompson KJ, Clase CM. Outcomes of acute coronary syndrome in a large Canadian cohort: impact of chronic renal insufficiency, cardiac, interventions, and anemia. Am J Kidney Dis 2005;46:845–855.

    Article  PubMed  Google Scholar 

  53. Brugts JJ, Knetsch AM, Mattace-Raso FUS, Hofman A, Witteman JCM. Renal function and risk of myocardial infarction in an elderly population, The Rotterdam Study. Arch Intern Med 2005;165:2659–2665.

    Article  PubMed  Google Scholar 

  54. De Nicola L, Minutolo R, Chiodini P, Zoccali C, Castellino P, Donadio C, Strippoli M, Casino F, Giannattasio M, Petrarulo F, Virgilio M, Llaraia E, Di Iorio BR, Savica V, Conte G. Global approach to cardiovascular risk in chronic kidney disease: Realty and opportunities for intervention. Kidney Int 2006;69:538–545.

    Article  PubMed  Google Scholar 

  55. Shlipak MG, Fried LF, Cushman M, Manolio TA, Peterson D, Stehman-Breen C, Bleyer A, Newman A, Siscovick D, Psaty B. Cardiovascular mortality risk in chronic kidney disease, comparison of traditional and novel risk factors. JAMA 2005;293:1737–1745.

    Article  PubMed  CAS  Google Scholar 

  56. Toto RD. Treatment of hypertension in chronic kidney disease. Semin Nephrol 2005;25:435–439.

    Article  PubMed  Google Scholar 

  57. Sica D, Carl D. Pathologic basis and treatment considerations in chronic kidney disease-related hypertension. Semin Nephrol 2005;25:246–251.

    PubMed  CAS  Google Scholar 

  58. De Nicola L, Minutolo R, Zamboli P, Cestaro R, Marzano L, Giannattasio P, Cristofano C, Chimienti S, Savica V, Bellinghieri G, Rapisarda F, Fatuzzo P, Conte G. Italian audit on therapy of hypertension in chronic kidney disease: The TABLE-CKD Study. Semin Nephrol 2005;25:425–430.

    Article  PubMed  Google Scholar 

  59. Appel LJ, Brands MW, Daniels SR, Karanja N, Elmer PJ, Sacks FM. Dietary Approaches to Prevent and Treat Hypertension: A Scientific Statement From the American Heart Association. Hypertension 2006;47:296–308.

    Article  PubMed  CAS  Google Scholar 

  60. Conlin PR, Chow D, Miller ER, Svetkey LA, Lin PH, Harsha DW, Moore TJ, Sacks FM, Appel LJ. The effect of dietary patterns on blood pressure control in hypertensive patients: Results from the Dietary Approaches to Stop Hypertension (DASH) Trial. Am J Hypertens 2000;13:949–955.

    Article  PubMed  CAS  Google Scholar 

  61. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, Obarzanek E, Conlin PR, Miller ER, Simons-Morton DG, Karanja N, Lin PH. Effects on blood pressure of reduced Dietary Sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. N Engl J Med 2001;344:3–10.

    Article  PubMed  CAS  Google Scholar 

  62. NKF KDOQI clinical practice guidelines for managing dyslipidemias in chronic kidney disease. Am J Kidney Dis 2003;41:S22–S58. (Guideline 1–4).

    Article  Google Scholar 

  63. Seliger SL, Weiss NS, Gillen DL, Kestenbaum B, Ball A, Sherrard DJ, Stehman-Breen CO. HMG-CoA reductase inhibitors are associated with reduced mortality in ESRD patients. Kidney Int 2002;61:297–304.

    Article  PubMed  CAS  Google Scholar 

  64. Fried LF, Orchard TJ, Kasiske BL. The effect of lipid reduction on renal disease progression: A meta-analysis. Kidney Int 2001;59:260–269.

    Article  PubMed  CAS  Google Scholar 

  65. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486–2497.

    Article  Google Scholar 

  66. Donadio JV. The emerging role of omega-3 polyunsaturated fatty acids in the management of patients with IgA nephropathy. J Ren Nutr 2001;11:122–128.

    Article  PubMed  CAS  Google Scholar 

  67. Pettersson EE, Rekola S, Berglund L, Sundqvist KG, Angelin B, Diczfalusy U, Bjorkhem I, Bergstrom J. Treatment of IgA nephropathy with omega-3-polyunsaturated fatty acids: a prospective, double-blind, randomized study. Clin Nephrol 1994;41:183–190.

    PubMed  CAS  Google Scholar 

  68. Souba WW, Wilmore DW. Diet and nutrition in the care of the patient with surgery, trauma, and sepsis. In: Shils ME, Olson JA, Shike M, Ross AC, ed. Modern Nutrition in Health and Disease, 9th edn. Philadelphia: Lippincott Williams & Wilkins, 1999, p. 1609.

    Google Scholar 

  69. Donadio JV, Larson TS, Bergstralh EJ, Grande JP. A randomized trial of high-dose compared with low-dose omega-3 fatty acids in severe IgA nephropathy. J Am Soc Nephrol 2001;12:791–799.

    PubMed  CAS  Google Scholar 

  70. Genin G, Laurent B, Sabatier JC, Colon S, Berthoux FC. IgA mesangial deposits in C3H/He mice after oral immunization with ferritin or bovine serum albumin. Clin Exp Immunol 1986;63:385–391.

    PubMed  CAS  Google Scholar 

  71. Ferri C, Puccini R, Longombardo G, Paleologo G, Migliorini P, Moriconi L, Pasero G, Cioni L. Low-antigen-content diet in the treatment of patients with IgA nephropathy. Nephrol Dial Transplant 1993;8:1193–1198.

    PubMed  CAS  Google Scholar 

  72. Ferri C, Puccini R. Low-Antigen-Content Diet. http://www.do.med.unipi.it/apher/write/diet.htm. Accessed April 1, 2006

    Google Scholar 

  73. Vlassara H. Advanced glycation in health and disease, role of the modern environment. Ann N Y Acad Sci 2005;1043:452–460.

    Article  PubMed  CAS  Google Scholar 

  74. Uribarri J, Cai W, Sandu O, Peppa M, Goldberg T, Vlassara H. Diet-derived advanced glycation end products are major contributors to the body’s AGE pool and induce inflammation in healthy subjects. Ann N Y Acad Sci 2005;1043:461–466.

    Article  PubMed  CAS  Google Scholar 

  75. Vlassara H, Cai W, Crandall J, Goldberg T, Oberstein R, Dardaine V, Peppa M, Rayfield EJ. Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy. Proc Natl Acad Sci USA 2002:99:15596–15601.

    Article  PubMed  CAS  Google Scholar 

  76. Lapolla A, Fedele D, Reitano R, Bonfante L, Pastori G, Seraglia R, Tubaaro M, Traldi P. Advanced glycation end products/peptides. Ann N Y Acad Sci 2005;1043:267–275.

    Article  PubMed  CAS  Google Scholar 

  77. Stipanuk MH. Biochemical and Physiological Aspects of Human Nutrition. Philadelphia: Saunders, 2000, pp. 9–11.

    Google Scholar 

  78. Uribarri J, Peppa M, Cai W, Goldberg T, Lu M, He C, Vlassara H. Restriction of dietary glycotoxins reduces excessive advanced glycation end products in renal failure patients. J Am Soc Nephrol 2003;14:728–731.

    Article  PubMed  CAS  Google Scholar 

  79. Uribarri J, Peppa M, Cai W, Goldberg T, Lu M, Suresh B, Vassolotti J, Vlassara H. Dietary glycotoxins correlate with circulating advanced glycation end product levels in renal failure patients. Am J Kidney Dis 2003;42:532–538.

    Article  PubMed  CAS  Google Scholar 

  80. Gillis BP, Caggiula AW, Chiavacci AT, Coyne T, Doroshendo L, Milas NC, Nowalk MP, Scherch LK. Nutrition intervention program of the Modification of Diet in Renal Disease Study: A self-management approach. J Am Diet Assoc 1995;96:1288–1294.

    Article  Google Scholar 

  81. Milas NC, Nowalk MP, Akpele L, Castaldo L, Coyne T, Doroshenko L, Kigawa L, Korzec-Ramirez D, Scherch LK, Snetselaar L. Factors associated with adherence to the dietary protein intervention in the Modification of Diet in Renal Disease Study. J Am Diet Assoc 1995;96:1295–1300.

    Article  Google Scholar 

  82. Midgley JP, Matthew AG, Greenwood CM, Logan AG. Effect of reduced dietary sodium on blood pressure: A meta-analysis of randomized controlled trials. JAMA 1996;275:1590–1597.

    Article  PubMed  CAS  Google Scholar 

  83. Bodenheimer T, Lorig K, Holman H, Grumback K. Patient self-management of chronic disease in primary care. JAMA 2002;288:2469–2475.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Puget Sound Kidney Centers, Mountlake Terrace, Washington

    Kathy Schiro Harvey MS, RD, CSR

Authors
  1. Kathy Schiro Harvey MS, RD, CSR
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Nutritional Sciences, University of Medicine and Dentistry of New Jersey, 40 East Laurel Rd, Stratford, NJ, USA

    Laura D. Byham-Gray

  2. Division of Nephrology, Stanford University School of Medicine, 3333 California St, Stanford, CA, USA

    Glenn M. Chertow

  3. Department of Nutrition, C.W. Post Campus Long Island University, 720 Northern Blvd, Brookville, NY, USA

    Jerrilynn D. Burrowes

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Humana Press, Totowa, NJ

About this chapter

Cite this chapter

Harvey, K.S. (2008). Nutrition and Pharmacologic Approaches. In: Byham-Gray, L.D., Chertow, G.M., Burrowes, J.D. (eds) Nutrition in Kidney Disease. Nutrition and Health. Humana Press. https://doi.org/10.1007/978-1-59745-032-4_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-032-4_8

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-781-5

  • Online ISBN: 978-1-59745-032-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation